The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety

Beginning in December of 2019, a novel coronavirus, SARS-CoV-2, emerged in China and is now a global pandemic with extensive morbidity and mortality. With the emergence of this threat, an unprecedented effort to develop vaccines against this virus began. As vaccines are now being introduced globally...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Vaccine
Auteurs principaux: Black, Steven B., Law, Barbara, Chen, Robert T., Dekker, Cornelia L., Sturkenboom, Miriam, Huang, Wan-Ting, Gurwith, Marc, Poland, Greg
Format: Artigo
Langue:Inglês
Publié: Elsevier Ltd. 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936550/
https://ncbi.nlm.nih.gov/pubmed/33846042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2021.03.016
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires